Abrocitinib After Dupilumab in Adults With Atopic Dermatitis
Researchers sought to evaluate results from adults with moderate to severe atopic dermatitis who are treated with abrocitinib after being treated with dupilumab.
Atopic Dermatitis
Improvements in Skin Clearance Maintained With Lebrikizumab in Atopic Dermatitis Trials
The ADvocate 1 and ADvocate 2 trials evaluated lebrikizumab as monotherapy in patients aged 12 years and older weighing at least 40kg with moderate to severe atopic dermatitis.
Hormone Levels and Asthma, Rhinitis, and Eczema
Important clinical considerations for clinicians treating asthma, rhinitis, and atopic dermatitis are presented.
Acne Risk and Severity in Patients With AD Varies By Age and Sex
The prevalence, incidence, and risk for acne in adolescent and adult patients with atopic dermatitis (AD) is assessed.
Real-World Success of Dupilumab for Treating Atopic Dermatitis in Adolescents
A real-world study on the safety and efficacy of dupilumab as a treatment for atopic dermatitis in adolescents was conducted.
Sodium Intake Linked to Risk for Atopic Dermatitis
Increased consumption of dietary sodium may increase the risk for atopic dermatitis.
Clinical Signs and Symptoms of Diaper Dermatitis: A Review
To better standardize the symptoms and signs of diaper dermatitis, investigators reviewed the literature for all descriptive words used to define diaper dermatitis.
Ruxolitinib Cream Promising for Maximum-Use in Atopic Dermatitis
The safety and tolerability of ruxolitinib cream 1.5% for maximum-use in patients with atopic dermatitis is investigated.
The Role of Pro-Healing T-Cells in Wound Responses in an Atopic Environment
Atopic dermatitis-like symptoms in mice found differences in ear tissue features from AD-like mice and controls.
Dementia Risk Observed in Older Adults With Eczema
Is atopic dermatitis linked to dementia?
- Loading...
Loading...
Next post in Dermatitis
Loading... 
Loading...